Analyst Reco. ResMed, Inc.

Equities

RMD

US7611521078

Real-time Estimate Cboe BZX Other stock markets 15:23:08 02/05/2024 BST			5-day change	1st Jan Change
214.5 ^USD	-0.22%		+16.73%	+24.47%

04-26	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT
04-26	Top Midday Gainers	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KeyBanc Adjusts Price Target on ResMed to $238 From $227	04-26	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	04-26	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	04-26	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	04-26	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	04-26	MT
Needham Adjusts Price Target on ResMed to $236 From $224	04-26	MT
Morgan Stanley Adjusts Price Target on ResMed to $219 From $207	04-26	MT
RBC Adjusts Price Target on ResMed to $200 From $187	04-26	MT
Needham Adjusts ResMed's Price Target to $224 From $180, Maintains Buy Rating	04-01	MT
Morgan Stanley Adjusts Resmed’s Price Target to AU$31.80 From AU$28.60, Keeps at Overweight	03-06	MT
Evans & Partners Upgrades ResMed to Positive From Neutral, Price Target is AU$31	03-04	MT
Powell, the paper tiger	02-05
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking...	02-05
Mizuho Adjusts Price Target on ResMed to $215 From $195, Keeps Buy Rating	01-30	MT
Oppenheimer Raises ResMed Price Target to $205 From $185, Maintains Outperform Rating	01-30	MT
UBS Adjusts ResMed Price Target to $180 From $175, Maintains Neutral Rating	01-25	MT
Oppenheimer Raises ResMed Price Target to $185 From $175, Maintains Outperform Rating	01-25	MT
RBC Lifts Price Target on ResMed to $182 From $181, Cites 'Solid' Fiscal Q2 Results, Keeps Sector Perform Rating	01-25	MT
RBC Cuts Price Target on ResMed to $181 From $200, Keeps Sector Perform Rating	01-22	MT
JPMorgan Adjusts Price Target on ResMed to $195 From $160, Maintains Overweight Rating	01-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 10:55 am